Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition
Effect of n-3 Polyunsaturated Fatty Acid Lipid Emulsion on Parenteral Nutrition Associated Liver Disease
Sponsor: ASPEN Rhoads Research Foundation
Terminated
No more eligible patients could be identified.
Other terminated trials from ASPEN Rhoads Research Foundation
More terminations from ASPEN Rhoads Research Foundation
A PHASE3 clinical study on Total Parenteral Nutrition-induced Cholestasis, this trial is terminated or withdrawn. The trial is conducted by ASPEN Rhoads Research Foundation and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Jun 2018 — Oct 2020 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ASPEN Rhoads Research Foundation
- Foothills Medical Centre
- Fresenius Kabi
- Hamilton Health Sciences Corporation
- Johane Allard
- St. Boniface Hospital
- St. Paul's Hospital, Canada
- University of Alberta
For direct contact, visit the study record on ClinicalTrials.gov .